# Therapeutics in Active Prostate Cancer Surveillance

> **NCT03365297** · PHASE2 · COMPLETED · sponsor: **CCTU- Cancer Theme** · enrollment: 11 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** Apalutamide

## Key facts

- **NCT ID:** NCT03365297
- **Lead sponsor:** CCTU- Cancer Theme
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-05
- **Primary completion:** 2019-07-25
- **Final completion:** 2019-07-25
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2019-11-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03365297

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03365297, "Therapeutics in Active Prostate Cancer Surveillance". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03365297. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*